scholarly journals Oral estramustine phosphate and oral etoposide for the treatment of hormone‐refractory prostate cancer

2000 ◽  
Vol 7 (7) ◽  
pp. 243-247 ◽  
Author(s):  
Yoshiteru Sumiyoshi ◽  
Katsuyoshi Hashine ◽  
Hironori Nakatsuzi ◽  
Yokihiko Yamashita ◽  
Takashi Karashima
Keyword(s):  
Prostate Cancer ◽  
Oral Etoposide ◽  
Hormone Refractory Prostate Cancer ◽  
Estramustine Phosphate ◽  
Hormone Refractory

scholarly journals Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer

2009 ◽  
Vol 20 (3) ◽  
pp. 498-502 ◽  
Author(s):  
G. Spitaleri ◽  
D.V. Matei ◽  
G. Curigliano ◽  
S. Detti ◽  
F. Verweij ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Oral Etoposide ◽  
Hormone Refractory Prostate Cancer ◽  
Estramustine Phosphate ◽  
Hormone Refractory

Methotrexate and estramustine phosphate in the treatment of hormone-refractory prostatic carcinoma. Preliminary study

1992 ◽  
Vol 59 (1_suppl) ◽  
pp. 151-152
Author(s):  
T. Torelli ◽  
A.M. Bacchioni ◽  
P. Corrada ◽  
G.L. Leidi ◽  
G. Ordesi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostatic Carcinoma ◽  
High Rate ◽  
Hormone Refractory Prostate Cancer ◽  
Estramustine Phosphate ◽  
Number Of Patients ◽  
Low Toxicity ◽  
Preliminary Study ◽  
Hormone Refractory

The authors report preliminary results of a study performed on six patients with by advanced, hormone-refractory prostate cancer. These patients were treated by estramustine phosphate (10 mg/kg) and methotrexate (60 mg/mq). Low toxicity allows the use of this therapy in outpatient regimens. Moreover, the high rate of partial responses (five patients) shows the remarkable efficacy of this therapy, even if follow-up and number of patients are not sufficient to reach definitive conclusions.

Phase II Study of Estramustine, Oral Etoposide, and Vinorelbine in Hormone-Refractory Prostate Cancer

1997 ◽  
Vol 20 (4) ◽  
pp. 383-386 ◽  
Author(s):  
M. Colleoni ◽  
C. Graiff ◽  
G. Vicario ◽  
P. Nelli ◽  
G. Sgarbossa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Oral Etoposide ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

Estramustine Phosphate Based Chemotherapy for Hormone Refractory Prostate Cancer

2007 ◽  
Vol 48 (7) ◽  
pp. 684 ◽  
Author(s):  
Kyung Seok Han ◽  
Kang Su Cho ◽  
Seung Hwan Lee ◽  
Sung Joon Hong
Keyword(s):  
Prostate Cancer ◽  
Hormone Refractory Prostate Cancer ◽  
Estramustine Phosphate ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document